Zhongshan Hospital

Shanghai, Shanghai Municipality 200032

1 studies enrolling now · 3 studies all time

What they study most

Advanced Solid Tumors, Gastric Cancer, Gastroesophageal Junction Cancer, HER2-Positive Advanced Solid Tumor, HER2-Positive Salivary Gland Carcinomas, HER2-positive Biliary Tract Cancer, HER2-positive Breast Cancer

Studies at this site

• First-in-Human Trial of VBC108 in Participants With Advanced Malignant Solid Tumors — Starting soon
• Safety of GQ1001 in Adult Patients With HER2-Positive Advanced Solid Tumors — Status unconfirmed
• A Study of BBI608 Plus Weekly Paclitaxel to Treat Gastric and Gastro-Esophageal Junction Cancer — Completed